Regulatory News:
SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814), the highly innovative medical imaging company that invented ShearWave™ Elastography and UltraFast Doppler, announced today that it will present at the Cowen and Company 35th Annual Health Care Conference in Boston, MA. Jacques Souquet, Chief Executive Officer, is scheduled to present on Wednesday, March 4th at 10:00a.m. ET.
About SuperSonic Imagine
Founded in 2005 and based in
Aix-en-Provence (France), SuperSonic Imagine is a company specializing
in medical imaging. The company designs, develops and markets a
revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform
that can acquire images 200 times faster than conventional ultrasound
systems. Aixplorer® is the only system that can image two types of
waves: ultrasound waves ensure excellent image quality and shear waves,
which allow physicians to visualize and analyze the stiffness of tissue
in a real-time, reliable, reproducible and non-invasive manner. This
innovation, ShearWave™ Elastography, significantly improves the
detection and characterization of numerous pathologies in several
applications including breast, thyroid, liver and prostate. SuperSonic
Imagine has been granted regulatory clearances for the commercialization
of Aixplorer® in the main global markets. Over the past years,
SuperSonic Imagine enjoyed the backing of several prestigious investors,
among which Auriga Partners, Edmond de Rothschild Investment Partners,
Bpifrance, Omnes Capital and NBGI. For more information about SuperSonic
Imagine, please go to www.supersonicimagine.com.
Contacts:
Marketing & Communication
Emmanuelle
Vella
emmanuelle.vella@supersonicimagine.com
+33
4 86 79 03 27
or
NewCap
Investor Relations - EU
Pierre
Laurent / Florent Alba
supersonicimagine@newcap.fr
+33
1 44 71 98 55
or
Blueprint Life Science Group
Investor
Relations - US
Candice Knoll
cknoll@bplifescience.com
415
375 3340 Ext. 105
or
ComCorp
Media Relations
Florence
Portejoie
fportejoie@comcorp.fr
+33
1 58 18 32 58 - +33 6 88 84 81 74
Adelaïde Manester
amanester@comcorp.fr
+33
1 58 18 32 58 - +33 6 70 45 74 37